FDA Streamlines Innovation for Opioid Use Disorder Devices

"The FDA continues to seek new ways to advance science to address the public health challenges that families and communities across the country face," said...

July 28, 2023 | Friday | News
EmVenio Research & TrialHub Partner to Boost Clinical Trial Efficiency

Through TrialHub's data intelligence gathering platform, EmVenio can easily identify optimal markets to attract clinical trial participants who are needed ...

July 28, 2023 | Friday | News
AWS Launches AWS HealthScribe: AI-Powered Clinical Documentation Service

New service leverages speech recognition and generative AI to automatically create preliminary clinical documentation from patient-clinician conversations ...

July 27, 2023 | Thursday | News
Singapore's National Dental Research Institute Launches Global Oral Diseases Consortium

National Dental Centre Singapore’s research arm, the National Dental Research Institute Singapore (NDRIS) has established an international collaborat...

July 26, 2023 | Wednesday | News
Lenacapavir Shows Sustained Impact on HIV Patients' Quality of Life

Analyses Show Oral Bridging Maintains Virologic Suppression When Subcutaneous Lenacapavir Doses are Missed – Gilead Sciences, Inc. (Na...

July 26, 2023 | Wednesday | News
IntelGenx Reports Promising Progress in Montelukast VersaFilm® Collaboration for Parkinson's Disease Treatment

IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx")  announced the execution of a Research Grant Agreement with Karolinska Unive...

July 26, 2023 | Wednesday | News
Lupin Emphasizes In-Home Cardiovascular Care with Digital Therapeutics

India based Lupin Digital Health and the American College of Cardiology (ACC) have announced a first-of-its-kind collaboration to deliver in-home cardiovas...

July 25, 2023 | Tuesday | News
China's SunHo Initiates Phase I/II Trial for First-in-Class Immunocytokine IBB0979

"We are excited for achieving this important milestone, which also marked the first step to what we hope will ultimately allow us to bring an innovative ca...

July 24, 2023 | Monday | News
Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility

Pfizer confirms all its colleagues are safe following a tornado that damaged predominantly the warehouse portion of its manufacturing facility in Rocky M...

July 24, 2023 | Monday | News
Integrated Biosciences Unveils Synthetic Biology Platform for Aging-Associated Stress Response Control

Optogenetic platform will be combined with AI at Integrated Biosciences to identify candidate anti-aging drugs Scientists demonstrate that cells make an i...

July 20, 2023 | Thursday | News
HUTCHMED's Fruquintinib Combo Receives Breakthrough Designation in China for Advanced Endometrial Cancer, Enrollment Complete

It is a multi-center, open-label clinical study to evaluate the efficacy and safety of fruquintinib in combination with sintilimab. Entry criteria include ...

July 20, 2023 | Thursday | News
AES Clean Technology achieves LEED certification for its cleanroom architectural system

LEED is a globally recognized symbol of sustainability achievement and leadership, and is a key milestone for AES, enabling it to meet increased customer d...

July 20, 2023 | Thursday | News
Neumora Therapeutics Begins Phase 3 Program for NMRA-140 in Major Depressive Disorder

Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the planned init...

July 19, 2023 | Wednesday | News
HNL Lab Medicine Announces Groundbreaking Digital Pathology Investment

The initiative combines Proscia’s innovative digital pathology software platform Concentriq Dx and Leica Biosystems’ scanner hardware. Proscia&...

July 19, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close